Effect of Clarithromycin Treatment on Chlamydia pneumoniae in Vascular Tissue of Patients with Coronary Artery Disease: a Randomized, Double-Blind, Placebo-Controlled Trial

Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial

The Lancet ◽

10.1016/s0140-6736(17)32458-3 ◽

2018 ◽

Vol 391 (10117) ◽

pp. 205-218 ◽

Cited By ~ 141

Author(s):

Stuart J Connolly ◽

John W Eikelboom ◽

Jackie Bosch ◽

Gilles Dagenais ◽

Leanne Dyal ◽

...

Keyword(s):

Coronary Artery Disease ◽

Coronary Artery ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

A randomized double-blind placebo-controlled trial of the effect of homocysteine-lowering therapy with folic acid on endothelial function in patients with coronary artery disease

ACC Current Journal Review ◽

10.1016/s1062-1458(01)00465-2 ◽

2001 ◽

Vol 10 (6) ◽

pp. 31-32

Author(s):

J Thambyrajah ◽

M.J Landray ◽

H.J Jones ◽

F.J McGlynn ◽

D.C Wheeler ◽

...

Keyword(s):

Coronary Artery Disease ◽

Folic Acid ◽

Coronary Artery ◽

Endothelial Function ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Lowering Therapy ◽

A randomized double-blind placebo-controlled trial of the effect of homocysteine-lowering therapy with folic acid on endothelial function in patients with coronary artery disease

Journal of the American College of Cardiology ◽

10.1016/s0735-1097(01)01235-9 ◽

2001 ◽

Vol 37 (7) ◽

pp. 1858-1863 ◽

Cited By ~ 46

Author(s):

Jeetendra Thambyrajah ◽

Martin J Landray ◽

Heather J Jones ◽

Fiona J McGlynn ◽

David C Wheeler ◽

...

Keyword(s):

Coronary Artery Disease ◽

Folic Acid ◽

Coronary Artery ◽

Endothelial Function ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Lowering Therapy ◽

Rationale, design, and baseline characteristics of the Study assessInG the morbidity-mortality beNefits of the If inhibitor ivabradine in patients with coronarY artery disease (SIGNIFY trial): A randomized, double-blind, placebo-controlled trial of ivabradine in patients with stable coronary artery disease without clinical heart failure

American Heart Journal ◽

10.1016/j.ahj.2013.06.024 ◽

2013 ◽

Vol 166 (4) ◽

pp. 654-661.e6 ◽

Cited By ~ 20

Author(s):

Kim Fox ◽

Ian Ford ◽

Philippe Gabriel Steg ◽

Jean-Claude Tardif ◽

Michal Tendera ◽

...

Keyword(s):

Heart Failure ◽

Coronary Artery Disease ◽

Coronary Artery ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Baseline Characteristics ◽

Clinical Heart Failure ◽

Faculty Opinions recommendation of Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.732115137.793543880 ◽

2018 ◽

Author(s):

Gad Cotter ◽

Olga Milo

Keyword(s):

Coronary Artery Disease ◽

Coronary Artery ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

P4-158: Omega-3 Fatty Acids and Cognitive Performance in Coronary Artery Disease Patients: A Secondary Analysis of a Randomized, Double-Blind, Placebo-Controlled Trial

Alzheimer s & Dementia ◽

10.1016/j.jalz.2016.06.2250 ◽

2016 ◽

Vol 12 ◽

pp. P1075-P1075

Author(s):

Nathan Herrmann ◽

Graham Mazereeuw ◽

Paul I. Oh ◽

David W.L. Ma ◽

Alexander Kiss ◽

...

Keyword(s):

Coronary Artery Disease ◽

Fatty Acids ◽

Coronary Artery ◽

Controlled Trial ◽

Secondary Analysis ◽

Omega 3 Fatty Acids ◽

Omega 3 ◽

Double Blind ◽

Double Blind Placebo ◽

Baicalin reduces blood lipids and inflammation in patients with coronary artery disease and rheumatoid arthritis: a randomized, double-blind, placebo-controlled trial

Lipids in Health and Disease ◽

10.1186/s12944-018-0797-2 ◽

2018 ◽

Vol 17 (1) ◽

Cited By ~ 11

Author(s):

Yuanxing Hang ◽

Xian Qin ◽

Tianli Ren ◽

Jianing Cao

Keyword(s):

Rheumatoid Arthritis ◽

Coronary Artery Disease ◽

Coronary Artery ◽

Blood Lipids ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

A multicenter, randomized, double-blind, placebo-controlled trial evaluating the efficacy and safety of Taoren Honghua Jian granule in patients with stable coronary artery disease

Medicine ◽

10.1097/md.0000000000017753 ◽

2019 ◽

Vol 98 (44) ◽

pp. e17753 ◽

Cited By ~ 1

Author(s):

Yiru Wang ◽

Yiyi Zhang ◽

Yiyue Du ◽

Ying Yang ◽

Jing Wei ◽

...

Keyword(s):

Coronary Artery Disease ◽

Coronary Artery ◽

Controlled Trial ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Faculty Opinions recommendation of Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1122755.579832 ◽

2008 ◽

Author(s):

Wolfgang Schoels

Keyword(s):

Coronary Artery Disease ◽

Left Ventricular Systolic Dysfunction ◽

Controlled Trial ◽

Systolic Dysfunction ◽

Left Ventricular ◽

Ventricular Systolic Dysfunction ◽

Double Blind ◽

Double Blind Placebo ◽

Exploring the potential of low-dose sulfasalazine in stable coronary artery disease patients: randomized, double-blind, placebo-controlled study

European Heart Journal - Cardiovascular Pharmacotherapy ◽

10.1093/ehjcvp/pvv021 ◽

2015 ◽

Vol 1 (4) ◽

pp. 214-216 ◽

Cited By ~ 3

Author(s):

Kanchan Vohra ◽

Pawan Krishan ◽

Sudhir Varma ◽

Harpreet Singh Kalra

Keyword(s):

Coronary Artery Disease ◽

Coronary Artery ◽

Low Dose ◽

Controlled Study ◽

Double Blind ◽

Double Blind Placebo ◽